Polar Asset Management Partners’s Japer Therapeutics Warrants JSPRW Stock Holding History

Polar Asset Management Partners’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-162,500	Closed	-$236K	–	1035
2020 Q4	$236K	Hold	162,500	–	–	﹤0.01%	716
2020 Q3	$192K	Hold	162,500	–	–	﹤0.01%	550
2020 Q2	$162K	Hold	162,500	–	–	﹤0.01%	452
2020 Q1	$106K	Buy	+162,500	New	+$128K	﹤0.01%	381

Other funds holding JSPRW

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $244M AUM 110.95% 1-Year Est. Return

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Polar Asset Management Partners's JSPRW Position: Q1 2021 in Review

Polar Asset Management Partners sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2021, closing a stake of 162,500 shares — an estimated $236K sold.

Polar Asset Management Partners first reported a position in JSPRW in Q1 2020 and held it in 4 quarters. The position peaked at $236K in Q4 2020. 26 funds tracked by Wall St. Rank hold JSPRW as of Q1 2021.

Polar Asset Management Partners reported no remaining Japer Therapeutics Warrants position as of Q1 2021 after selling out during the quarter.
Polar Asset Management Partners sold 162,500 Japer Therapeutics Warrants shares in Q1 2021, an estimated $236K.
Polar Asset Management Partners first reported a position in Japer Therapeutics Warrants in Q1 2020 and held it in 4 quarters.
Polar Asset Management Partners's Japer Therapeutics Warrants position peaked at $236K in Q4 2020.
26 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2021.

Based on Polar Asset Management Partners's 13F filing for Q1 2021, filed 17 May 2021.